Dextran, low molecular weight Pregnancy and Breastfeeding Warnings

Dextran, low molecular weight is also known as: Dextran 40, Dextran 40 in 0.9% Sodium Chloride, Dextran 40 in 5% Dextrose, Gentran 40, Gentran 40 with 0.9% Sodium Chloride, Gentran 40 with 5% Dextrose, LMD with 0.9% Sodium Chloride, LMD with 5% Dextrose, Rheomacrodex

Dextran, low molecular weight Pregnancy Warnings

This drug should be used during pregnancy only if the benefit outweighs the risk.

US FDA pregnancy category: Not assigned.

Risk Summary: Animal reproduction studies have not been conducted with this drug.

Comments:
-The effects in the developing fetus are unknown.

Animal studies have not been conducted with this drug. There are no controlled data in human pregnancy. It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.

See references

Dextran, low molecular weight Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-The effects in the nursing infant are unknown.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer